QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buxton, I. L. O. Search for Related Content PubMed PubMed Citation Articles by Buxton, I. L. O.

Minireview

Regulation of Uterine Function: a Biochemical Conundrum in the Regulation of Smooth Muscle Relaxation

Department of Pharmacology, University of Nevada School of Medicine, Reno, Nevada

Premature birth accounts for the majority of fetal morbidity and mortality in the developed world and is disproportionately represented in some populations, such as African Americans in the United States. The costs associated with prematurity are staggering in both monetary and human terms. Present therapeutic approaches for the treatment of labor leading to preterm delivery are inadequate and our understanding of the regulation of myometrial smooth muscle contraction-relaxation is incomplete. The ability of nitric oxide to relax smooth muscle has led to an interest in employing nitric oxide-donors in the treatment of preterm labor. Fundamental differences exist, however, in the regulation of uterine smooth muscle relaxation and that of other smooth muscles and constitute a conundrum in our understanding. We review the evidence that nitric oxide-mediated relaxation of myometrial smooth muscle, unlike vascular or gastrointestinal smooth muscle, is independent of global elevation of cyclic guanosine 5'-monophosphate. Applying our current understanding of microdomain signaling and taking clues from genomic studies of pregnancy, we offer a framework in which to view the apparent conundrum and suggest testable hypotheses of uterine relaxation signaling that can explain the mechanistic distinctions. We propose that understanding these mechanistic distinctions in myometrium will reveal molecular targets that are unique and thus may be explored as therapeutic targets in the development of new uterine smooth muscle-specific tocolytics.

Address correspondence to: Iain L. O. Buxton, Professor of Pharmacology, University of Nevada School of Medicine MS318, 1664 N. Virginia Street, Reno, NV 89557. E-mail: buxton{at}med.unr.edu

This article has been cited by other articles:

				J. A. Carvajal, A. M. Delpiano, M. A. Cuello, J. A. Poblete, P. C. Casanello, L. A. Sobrevia, and C. P. Weiner Brain Natriuretic Peptide (BNP) Produced by the Human Chorioamnion May Mediate Pregnancy Myometrial Quiescence Reproductive Sciences, January 1, 2009; 16(1): 32 - 42. [Abstract] [PDF]

				A. Brown, T. Cornwell, I. Korniyenko, V. Solodushko, C. T. Bond, J. P. Adelman, and M. S. Taylor Myometrial expression of small conductance Ca2+-activated K+ channels depresses phasic uterine contraction Am J Physiol Cell Physiol, February 1, 2007; 292(2): C832 - C840. [Abstract] [Full Text] [PDF]

				B. M. Sanborn, C.-Y. Ku, S. Shlykov, and L. Babich Molecular Signaling Through G-Protein-Coupled Receptors and the Control of Intracellular Calcium in Myometrium Reproductive Sciences, October 1, 2005; 12(7): 479 - 487. [Abstract] [PDF]

				M. Thompson, H. Barata da Silva, W. Zielinska, T. A. White, J. P. Bailey, F. E. Lund, G. C. Sieck, and E. N. Chini Role of CD38 in myometrial Ca2+ transients: modulation by progesterone Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1142 - E1148. [Abstract] [Full Text] [PDF]